Honored to lead Cardurion Pharmaceuticals' oversubscribed $260M Series B round alongside existing investor Bain Capital Life Sciences Fund LP and new investors New Enterprise Associates (NEA), GV (Google Ventures), Fidelity Management And Research Company, Millennium, Farallon Capital Management, The Invus Group, Blue Owl Capital, Delos Capital and Digitalis Ventures. Looking forward to partnering with Peter Lawrence and his spectacular team on this next chapter!
About us
Ascenta Capital invests in biotechs.
- Website
-
ascentacap.com
External link for Ascenta Capital
- Industry
- Venture Capital and Private Equity Principals
- Company size
- 2-10 employees
- Type
- Partnership
- Founded
- 2023
Employees at Ascenta Capital
Updates
-
Excited to announce we led Odyssey Therapeutics’s $101M Series C, with participation from an outstanding group of new and existing investors. We’re looking forward to working with Dr. Gary D. Glick and the incredibly talented Odyssey team as they pioneer a portfolio of transformative immunology and oncology medicines!
-
Delighted to co-lead Iambic's oversubscribed $100M Series B with Abingworth and Kurt von Emster, along with new investors NVIDIA, Illumina Ventures, gradiant, and board member Bill Rastetter. Also energized by existing investor participation from Catalio Capital Management, Coatue, FreeFlow Ventures, OrbiMed, and Sequoia Capital. Excited to help Dr. Thomas Miller and his extraordinary team as they continue to build this exceptional company!
Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIA
finance.yahoo.com
-
Congrats to our portfolio company, ADARx Pharmaceuticals Inc., on their oversubscribed $200M Series C round, co-led by Bain Capital Life Sciences Fund LP and TCGX. We are delighted to have participated in this round, alongside a stellar group of new and existing investors. Dr. Zhen Li and her team continue to make extraordinary progress with their platform!
ADARx Nets $200M for Lead siRNA Drug Candidates
https://www.insideprecisionmedicine.com